Birch Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Sell
4,266
-348
-8% -$74.9K 0.52% 42
2026
Q1
$1M Sell
4,614
-808
-15% -$179K 0.53% 40
2025
Q4
$1.24M Sell
5,422
-18
-0.3% -$4.1K 0.62% 36
2025
Q3
$1.26M Sell
5,440
-4,540
-45% -$925K 0.64% 38
2025
Q2
$1.85M Hold
9,980
0.95% 28
2025
Q1
$2.09M Sell
9,980
-160
-2% -$31.1K 1.09% 29
2024
Q4
$1.8M Sell
10,140
-7
-0.1% -$1.29K 0.91% 31
2024
Q3
$2M Sell
10,147
-502
-5% -$93.7K 0.98% 32
2024
Q2
$1.83M Hold
10,649
0.95% 35
2024
Q1
$1.94M Sell
10,649
-1,939
-15% -$334K 1.01% 32
2023
Q4
$1.95M Sell
12,588
-356
-3% -$51.9K 1.12% 27
2023
Q3
$1.93M Hold
12,944
1.22% 25
2023
Q2
$1.74M Hold
12,944
1.06% 30
2023
Q1
$2.06M Hold
12,944
1.33% 25
2022
Q4
$2.09M Hold
12,944
1.44% 23
2022
Q3
$1.74M Hold
12,944
1.31% 24
2022
Q2
$1.98M Hold
12,944
1.42% 26
2022
Q1
$2.1M Hold
12,944
1.29% 28
2021
Q4
$1.75M Sell
12,944
-748
-5% -$88.4K 1.05% 27
2021
Q3
$1.48M Sell
13,692
-447
-3% -$51.1K 1% 29
2021
Q2
$1.59M Hold
14,139
1.08% 31
2021
Q1
$1.53M Sell
14,139
-991
-7% -$106K 1.13% 31
2020
Q4
$1.62M Hold
15,130
1.24% 28
2020
Q3
$1.32M Sell
15,130
-748
-5% -$70.4K 1.15% 30
2020
Q2
$1.56M Sell
15,878
-2,113
-12% -$186K 1.46% 24
2020
Q1
$1.37M Sell
17,991
-1,540
-8% -$131K 1.58% 24
2019
Q4
$1.73M Buy
+19,531
New +$1.62M 1.69% 24

Other funds holding ABBV

Birch Capital Management's ABBV Position: Q2 2026 in Review

Birch Capital Management reduced its AbbVie (ABBV) stake by 7.5% in Q2 2026, selling an estimated $74.9K and leaving 4,266 shares worth $1.07M. The position accounts for 0.52% of the portfolio, ranked #42.

Birch Capital Management first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.1M in Q1 2022. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Birch Capital Management held 4,266 shares of AbbVie worth $1.07M as of Q2 2026.
  • Birch Capital Management sold 348 AbbVie shares in Q2 2026, an estimated $74.9K.
  • AbbVie made up 0.52% of Birch Capital Management's portfolio in Q2 2026, its #42 holding.
  • Birch Capital Management first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • Birch Capital Management's AbbVie position peaked at $2.1M in Q1 2022.
  • 1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Birch Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.